Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
In the last 90 days, Passage BIO, Inc. insiders filed 1 open-market purchase and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Passage BIO, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −6 vs. Q1 2024
- Shares held
- 40.3M
- −25.6K (−0.1%) vs. Q1 2024
- Total value
- $32.0M
- −$22.4M (−41.2%) vs. Q1 2024
- New holders
- 3
- 8 more added
- Sold out
- 9
- 11 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $33.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.1M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 10,124,576 | $8.04M | 0.16% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 6,052,000 | $4.81M | 0.36% | +1,552,000+34.5% | Added |
| Lynx1 Capital Management LP | 5,057,629 | $4.02M | 1.45% | +211,758+4.4% | Added |
| Versant Venture Management, LLC | 4,026,417 | $3.20M | 4.14% | −933,352−18.8% | Reduced |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1.98M | 2.41% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 2,455,800 | $1.96M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,071,538 | $1.65M | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,500,000 | $1.19M | 0.12% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,125,574 | $893.9K | 0.00% | −79,950−6.6% | Reduced |
| Acadian Asset Management LLC | 961,271 | $762.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 817,529 | $649.3K | 0.00% | −105,018−11.4% | Reduced |
| Millennium Management LLC | 750,926 | $596.4K | 0.00% | −114,813−13.3% | Reduced |
| Bridgeway Capital Management, LLC | 556,142 | $441.7K | 0.01% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 471,812 | $374.7K | 0.20% | +2,506+0.5% | Added |
| Geode Capital Management, LLC | 431,110 | $342.5K | 0.00% | +46,832+12.2% | Added |
| Affinity Asset Advisors, LLC | 264,266 | $209.9K | 0.03% | 00.0% | Unchanged |
| Fiduciary Trust Co | 215,000 | $170.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 158,261 | $125.7K | 0.00% | −63,291−28.6% | Reduced |
| RBF Capital, LLC | 142,807 | $113.4K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 123,873 | $98.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 103,854 | $82.5K | 0.00% | −97,299−48.4% | Reduced |
| Marquette Asset Management, LLC | 85,500 | $67.9K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 64,512 | $51.2K | 0.00% | −19,755−23.4% | Reduced |
| DLK Investment Management, LLC | 64,000 | $50.8K | 0.02% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 27,233 | $21.6K | 0.00% | +279+1.0% | Added |
| Cresset Asset Management, LLC | 23,725 | $18.8K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 21,512 | $17.0K | 0.00% | −251−1.2% | Reduced |
| FMR LLC | 21,054 | $16.7K | 0.00% | −16−0.1% | Reduced |
| XTX Topco Ltd | 17,039 | $13.5K | 0.00% | −25,924−60.3% | Reduced |
| Morgan Stanley | 13,442 | $10.7K | 0.00% | −395−2.9% | Reduced |
| Tower Research Capital LLC (TRC) | 13,203 | $10.5K | 0.00% | +13,169+38,732.4% | Added |
| Barclays PLC | 13,153 | $10.4K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 693 | $1.00K | 0.00% | +193+38.6% | Added |
| UBS Group AG | 1,146 | $910 | 0.00% | +1,146 | New |
| Federated Hermes, Inc. | 783 | $622 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 783 | $621 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 400 | $318 | 0.00% | +400 | New |
| Bank of America Corp | 367 | $291 | 0.00% | +366+36,600.0% | Added |
| JPMorgan Chase & Co | 273 | $217 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 225 | $179 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 60 | $48 | 0.00% | +60 | New |
| Group One Trading, L.P. | 47 | $37 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 4 | $4 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −209,600−100.0% | Sold out |
| Pale Fire Capital SE | 0 | $0 | 0.00% | −141,435−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,425−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −21,990−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,290−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3,969−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −309−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −10−100.0% | Sold out |